Published in J Clin Microbiol on October 01, 1999
Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis (2007) 6.41
Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol (2006) 3.22
Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis. J Clin Microbiol (2006) 2.88
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J (2014) 2.28
Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation. J Clin Microbiol (2009) 1.98
Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol (2009) 1.94
Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother (2003) 1.93
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One (2012) 1.93
Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs. Eur J Clin Microbiol Infect Dis (2005) 1.80
Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrob Agents Chemother (2009) 1.68
Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother (2003) 1.54
Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method. Antimicrob Agents Chemother (2001) 1.40
Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin. J Clin Microbiol (2004) 1.27
Real-time PCR using mycobacteriophage DNA for rapid phenotypic drug susceptibility results for Mycobacterium tuberculosis. J Clin Microbiol (2011) 1.23
Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis. J Clin Microbiol (2014) 1.17
Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2012) 1.13
Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis. Curr Opin Infect Dis (2008) 1.07
Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays. J Clin Microbiol (2005) 1.02
Testing susceptibility of multidrug-resistant Mycobacterium tuberculosis to second-line drugs by use of blood agar. J Clin Microbiol (2010) 0.96
Quantitative drug-susceptibility in patients treated for multidrug-resistant tuberculosis in Bangladesh: implications for regimen choice. PLoS One (2015) 0.91
Isothermal RNA sequence amplification method for rapid antituberculosis drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2005) 0.90
Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual mycobacterium growth indicator tube system. J Clin Microbiol (2008) 0.89
From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study. PLoS One (2013) 0.88
Canadian multicenter laboratory study for standardized second-line antimicrobial susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2011) 0.88
Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid. Antimicrob Agents Chemother (2002) 0.85
Rapid detection of rpoB mutations in rifampin resistant M. tuberculosis from sputum samples by denaturing gradient gel electrophoresis. Int J Med Sci (2012) 0.81
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. Int J Mycobacteriol (2015) 0.80
Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex. Diagn Microbiol Infect Dis (2016) 0.80
Establishment of an in vitro D-cycloserine-synthesizing system by using O-ureido-L-serine synthase and D-cycloserine synthetase found in the biosynthetic pathway. Antimicrob Agents Chemother (2013) 0.79
Molecular detection and characterization of resistant genes in Mycobacterium tuberculosis complex from DNA isolated from tuberculosis patients in the Eastern Cape province South Africa. BMC Infect Dis (2014) 0.78
Implications of failure to routinely diagnose resistance to second-line drugs in patients with rifampicin-resistant tuberculosis on Xpert MTB/RIF: a multisite observational study. Clin Infect Dis (2017) 0.75
Reduced chance of hearing loss associated with Therapeutic Drug Monitoring of Aminoglycosides in the treatment of Multidrug Resistant Tuberculosis. Antimicrob Agents Chemother (2017) 0.75
Discovery of novel MDR-Mycobacterium tuberculosis inhibitor by new FRIGATE computational screen. PLoS One (2011) 0.75
The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol (1993) 11.70
Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol (1983) 10.49
Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (1981) 9.67
Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol (1999) 4.10
Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli. J Clin Microbiol (1997) 4.01
Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods. Am Rev Respir Dis (1987) 3.86
Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J Clin Microbiol (1999) 3.37
Testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by mycobacterium growth indicator tube method. J Clin Microbiol (1996) 3.37
Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J Clin Microbiol (1985) 2.68
In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii. Antimicrob Agents Chemother (1984) 2.65
Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare. Antimicrob Agents Chemother (1986) 2.62
Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs. J Clin Microbiol (1998) 2.58
Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis. Am Rev Respir Dis (1990) 2.24
Multicenter comparison of ESP Culture System II with BACTEC 460TB and with Lowenstein-Jensen medium for recovery of mycobacteria from different clinical specimens, including blood. J Clin Microbiol (1998) 2.16
Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Tubercle (1987) 2.01
Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimens. J Clin Microbiol (1998) 1.97
In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr Microbiol (1996) 1.81
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis. Am Rev Respir Dis (1993) 1.80
Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis. Antimicrob Agents Chemother (1989) 1.62
Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages. Am Rev Respir Dis (1992) 1.56
Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Res Microbiol (1989) 1.43
Stability of antimycobacterial drugs in susceptibility testing. Antimicrob Agents Chemother (1992) 1.43
Minimal inhibitory concentrations of rifabutin, ciprofloxacin, and ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in Taiwan. Am Rev Respir Dis (1989) 1.28
Amikacin in the treatment of pulmonary tuberculosis. Tubercle (1983) 1.23
Antituberculosis activities of clofazimine and its new analogs B4154 and B4157. Antimicrob Agents Chemother (1996) 1.16
Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis. Am Rev Respir Dis (1991) 1.08
Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrob Agents Chemother (1993) 0.86
Setting breakpoints for assessing the sensitivity of mycobacteria to rifabutin in vitro. J Antimicrob Chemother (1994) 0.82
In vitro activity of antimicrobial agents against mycobacteria. Drugs Exp Clin Res (1988) 0.81
Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J (1993) 11.30
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (1998) 10.78
Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science (1993) 10.09
Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J Bacteriol (1988) 8.18
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (2001) 6.05
Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother (1994) 5.64
EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis (2008) 4.88
The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol Gen Genet (1995) 4.63
A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus. J Bacteriol (1991) 4.23
Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol (1999) 4.10
Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens. J Clin Microbiol (1996) 3.85
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother (1997) 3.75
Conversion of a homogeneously methicillin-resistant strain of Staphylococcus aureus to heterogeneous resistance by Tn551-mediated insertional inactivation. Eur J Clin Microbiol (1986) 3.44
Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis. J Clin Microbiol (1994) 3.35
Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet (1995) 3.08
Timing and purpose of the MRCGP examination. J R Coll Gen Pract (1989) 2.84
Primary prevention of food allergy in children and adults: systematic review. Allergy (2014) 2.75
Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J Clin Microbiol (1985) 2.68
Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitro-alpha-acetylamino-beta-hydroxypropiophenone. J Clin Microbiol (1984) 2.39
Fourth report of the cooperative, open-ended study of slowly growing mycobacteria by the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1991) 2.31
Effect of vitamin and mineral supplementation on intelligence of a sample of schoolchildren. Lancet (1988) 2.31
pT181 plasmid replication is regulated by a countertranscript-driven transcriptional attenuator. Cell (1989) 2.28
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis (2008) 2.25
Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates. J Clin Microbiol (1993) 2.25
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir Res (2001) 2.25
The diagnosis of food allergy: a systematic review and meta-analysis. Allergy (2013) 2.23
Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol (2001) 2.21
Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis (2000) 2.18
Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70. J Biol Chem (1997) 2.14
Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope cleaning machine. Report of an outbreak and review of the literature. Chest (1992) 2.14
Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods. J Clin Microbiol (2002) 2.12
Localized upregulation of a new expansin gene predicts the site of leaf formation in the tomato meristem. Plant Cell (1998) 2.11
Conventional and radiometric drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol (1983) 2.08
EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy (2014) 2.05
The epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy (2013) 2.02
Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1996) 2.02
Drug tolerance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (1999) 1.94
The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy (2007) 1.91
Comparative sequence and functional analysis of pT181 and pC221, cognate plasmid replicons from Staphylococcus aureus. Mol Gen Genet (1985) 1.90
The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods (1993) 1.86
Evaluation of a polymerase chain reaction-based universal heteroduplex generator assay for direct detection of rifampin susceptibility of Mycobacterium tuberculosis from sputum specimens. Clin Infect Dis (1998) 1.83
Risk-adjusted analysis of surgeon performance: a 1-year study. Br J Surg (1995) 1.81
EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy (2014) 1.80
International consensus on (ICON) pediatric asthma. Allergy (2012) 1.79
Comments on Oxoid Signal blood culture system. J Clin Pathol (1987) 1.78
Test for differentiation of M. tuberculosis and M. bovis from other mycobacteria. Can J Microbiol (1978) 1.77
Mycobacterial identification by computer-aided gas-liquid chromatography. Diagn Microbiol Infect Dis (1994) 1.74
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy (2014) 1.73
The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol (1999) 1.73
Regulation of the protein A-encoding gene in Staphylococcus aureus. Gene (1992) 1.73
Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tuber Lung Dis (1994) 1.71
Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. Int J Tuberc Lung Dis (2008) 1.70
Emergence of fluoroquinolone-resistant tuberculosis in New York City. Lancet (1995) 1.70
Nucleotide sequence: the beta-hemolysin gene of Staphylococcus aureus. Nucleic Acids Res (1989) 1.67
Cloning and nucleotide sequence of a chromosomally encoded tetracycline resistance determinant, tetA(M), from a pathogenic, methicillin-resistant strain of Staphylococcus aureus. Antimicrob Agents Chemother (1990) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
An explanatory model of health promotion and quality of life in chronic disabling conditions. Nurs Res (2000) 1.66
Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City. J Infect Dis (1993) 1.62
Radiotherapy service delivery models for a dispersed patient population. Clin Oncol (R Coll Radiol) (2001) 1.61
Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 1.60
Prevalence of common food allergies in Europe: a systematic review and meta-analysis. Allergy (2014) 1.55
A site-specific recombination function in Staphylococcus aureus plasmids. J Bacteriol (1987) 1.55
Sexual selection and the evolution of evolvability. Heredity (Edinb) (2006) 1.54
A new agent of mycobacterial lymphadenitis in children: Mycobacterium heidelbergense sp. nov. J Clin Microbiol (1997) 1.52
Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med (1996) 1.51
The effect of healing on bile reflux in gastric ulcer. Gut (1971) 1.51
Comparison of RapID yeast plus system with API 20C system for identification of common, new, and emerging yeast pathogens. J Clin Microbiol (1998) 1.51
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Mol Immunol (1993) 1.50
Mycobacteriosis due to Mycobacterium genavense in six pet birds. J Clin Microbiol (1993) 1.49
Serovar determination and molecular taxonomic correlation in Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum: a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1993) 1.48
Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res (2000) 1.48
Evolutionary implications of phenotypic plasticity in the hindlimb of the lizard Anolis sagrei. Evolution (2000) 1.46
The management of stab wounds of the abdomen and thorax. Br J Surg (1966) 1.46
Immuno-PCR with a commercially available avidin system. Science (1993) 1.43
Towards sustainable delivery of health services in Afghanistan: options for the future. Bull World Health Organ (2007) 1.41
Replication control for pT181, an indirectly regulated plasmid. Basic Life Sci (1985) 1.41
Long-term facilitation in obstructive sleep apnea patients during NREM sleep. J Appl Physiol (1985) (2001) 1.40
High prevalence of FDB3500 mutation in the Swiss population. Atherosclerosis (2000) 1.39
Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther (1993) 1.38
Aggressive approach in the treatment of acute lead encephalopathy with an extraordinarily high concentration of lead. Arch Pediatr Adolesc Med (1998) 1.38
Prey scan at random to evade observant predators. Proc Biol Sci (2001) 1.36
False-positive results for Mycobacterium celatum with the AccuProbe Mycobacterium tuberculosis complex assay. J Clin Microbiol (2000) 1.35
Laboratory diagnosis of mycobacterial infections: new tools and lessons learned. Clin Infect Dis (2001) 1.34
Use of the National Committee for Clinical Laboratory Standards guidelines for disk diffusion susceptibility testing in New York state laboratories. J Clin Microbiol (2000) 1.34
Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis (1992) 1.32
A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Arch Intern Med (1997) 1.31
Lessons from a proficiency testing event for acid-fast microscopy. Chest (2001) 1.28
Identification of potent P2Y-purinoceptor agonists that are derivatives of adenosine 5'-monophosphate. Br J Pharmacol (1996) 1.27
Phosphorylation of HSP27 during development and decay of thermotolerance in Chinese hamster cells. J Cell Physiol (1991) 1.26
Improved methods for reducing calcium and magnesium concentrations in tissue culture medium: application to studies of lymphoblast proliferation in vitro. In Vitro (1976) 1.26
The epidemiology of anaphylaxis in Europe: a systematic review. Allergy (2013) 1.26
An analysis of a melanoma epidemic. Int J Cancer (1993) 1.25
Influence of a multidisciplinary paediatric allergy clinic on parental knowledge and rate of subsequent allergic reactions. Allergy (2004) 1.25
Adherence discourse among African-American women taking HAART. AIDS Care (2002) 1.22
Extrapulmonary and disseminated infections due to Mycobacterium malmoense: case report and review. Clin Infect Dis (1993) 1.21
Heat-resistant variants of Chinese hamster fibroblasts altered in expression of heat shock protein. Proc Natl Acad Sci U S A (1985) 1.20
Alga associated with diarrhea in patients with acquired immunodeficiency syndrome and in travelers. J Clin Microbiol (1990) 1.20
A short calcium infusion in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab (1974) 1.20
The prognosis of lupus nephritis. Role of clinical-pathologic correlations. Ann Intern Med (1968) 1.19
Resistance rather than virulence selects for the clonal spread of methicillin-resistant Staphylococcus aureus: implications for MRSA transmission. Microb Drug Resist (2000) 1.19